Literature DB >> 11201881

Leprosy chemoprophylaxis in Micronesia.

C Diletto1, L Blanc, L Levy.   

Abstract

A programme of chemoprophylaxis was introduced as a component of the leprosy control programme in the Federated States of Micronesia (FSM), beginning in 1996. The entire population of the country was to be screened, and a single dose of 600 mg rifampicin, 400 mg ofloxacin and 100 mg minocycline (ROM) was to be administered to the entire population. Two rounds of screening the entire population were carried out, approximately 1 year apart, and chemoprophylaxis was administered at the time of each screening. Ninety percent of the population were screened at least once, and 55% were screened in both rounds; 87% of the population received at least one dose, and 54% received two doses. In the course of the first round, 322 new cases were detected, whereas only 80 new cases were detected during the second round, of whom only 12 had received chemoprophylaxis in the course of the first round. A third round of screening, confined to a small number of villages in both Chuuk and Pohnpei, in which states leprosy endemicity was high, was carried out approximately 2 years after the second. Only 16 new cases were detected during the third round of screening, whereas 102 new cases had been detected in this same population during the first round of screening, and 32 new cases during the second. Six of the 16 newly detected cases stated that they had been administered chemoprophylaxis at least once; however, this information may not be reliable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201881     DOI: 10.5935/0305-7518.20000061

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  10 in total

1.  Leprosy elimination: not as straightforward as it seemed.

Authors:  Paul R Saunderson
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

2.  Chemoprophylaxis in the prevention of leprosy.

Authors:  W Cairns S Smith
Journal:  BMJ       Date:  2008-04-05

Review 3.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

Review 4.  The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.

Authors:  Anne Schoenmakers; Liesbeth Mieras; Teky Budiawan; Wim H van Brakel
Journal:  Res Rep Trop Med       Date:  2020-10-15

5.  Hansen disease among Micronesian and Marshallese persons living in the United States.

Authors:  Patricia Woodall; David Scollard; Latha Rajan
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

Review 6.  Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Authors:  Malcolm S Duthie; Marivic F Balagon
Journal:  Risk Manag Healthc Policy       Date:  2016-04-27

7.  Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.

Authors:  Tanja Barth-Jaeggi; Peter Steinmann; Liesbeth Mieras; Wim van Brakel; Jan Hendrik Richardus; Anuj Tiwari; Martin Bratschi; Arielle Cavaliero; Bart Vander Plaetse; Fareed Mirza; Ann Aerts
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

Review 8.  Chemoprophylaxis of Tropical Infectious Diseases.

Authors:  William J H McBride
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

9.  An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.

Authors:  Liesbeth F Mieras; Anna T Taal; Wim H van Brakel; Emmanuelle Cambau; Paul R Saunderson; W Cairns S Smith; Cita Rosita S Prakoeswa; Linda Astari; David M Scollard; Dejair Caitano do Nascimento; Jacques Grosset; Hemanta K Kar; Shinzo Izumi; Laura Gillini; Marcos C L Virmond; Marieke G G Sturkenboom
Journal:  BMC Infect Dis       Date:  2018-10-05       Impact factor: 3.090

10.  Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.

Authors:  Anuj Tiwari; Steaven Dandel; Rita Djupuri; Liesbeth Mieras; Jan Hendrik Richardus
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.